Albumin in sepsis resuscitation

The role of albumin in many clinical conditions has waned, primarily due to expense and intermittent shortages. In this meta-analysis of 17 studies (1977 participants), albumin (versus other IVF) was associated with a reduced mortality when used to resuscitate sepsis patients (Odds ratio=0.82, CI 0.67-1.0). According to this meta-analysis, the use of albumin in resuscitation of septic patients is reasonable, pending further randomized trials (abstract)

Danielle Scheurer

Dr. Scheurer is a clinical hospitalist and the Medical Director of Quality and Safety at the Medical University of South Carolina in Charleston, South Carolina, and is Assistant Professor of Medicine. She is a graduate of the University of Tennessee College of Medicine, completed her residency at Duke University, and completed her Masters in Clinical Research at the Medical University of South Carolina. She also serves as the Web Editor and Physician Advisor for the Society of Hospital Medicine.

Leave a Comment